Cargando…
Radioactive Body Burden Measurements in (131)Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body (131)Iodine Clearance
Protocols in the management of differentiated thyroid cancer, recommend adequate thyroid stimulating hormone (TSH) stimulation for radioactive (131)I administrations, both for imaging and subsequent ablations. Commonly followed method is to achieve this by endogenous TSH stimulation by withdrawal of...
Autores principales: | Ravichandran, Ramamoorthy, Al Saadi, Amal, Al Balushi, Naima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149771/ https://www.ncbi.nlm.nih.gov/pubmed/25191114 http://dx.doi.org/10.4103/1450-1147.138576 |
Ejemplares similares
-
Radioactive (131)Iodine Body Burden and Blood Dose Estimates in Treatment for Differentiated Thyroid Cancer by External Probe Counting
por: Ravichandran, Ramamoorthy, et al.
Publicado: (2016) -
Therapeutic applications of radioactive (131)iodine: Procedures and incidents with capsules
por: Al Aamri, Marwa, et al.
Publicado: (2016) -
Estimation of effective half life of clearance of radioactive Iodine ((131)I) in patients treated for hyperthyroidism and carcinoma thyroid
por: Ravichandran, R, et al.
Publicado: (2010) -
Radioactive iodine (I-131) therapy isolation rooms: Introduction of lead glass window on the wall for patient comfort and better ambience
por: Al Aamri, Marwa, et al.
Publicado: (2019) -
Iodine-131 and Thyroid Function
por: Sun, Wenjie
Publicado: (2014)